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ABSTRACT 
Background: Schmallenberg virus (SBV) is an orthobunyavirus carried by Culicoides biting 
midges that cause reproductive problems in adult ruminants when infected during their 
gestation period. SBV was first detected in ruminants in the UK in 2011/12 and then again in 
2016. The reason behind the 2016 re-emergence of SBV is unknown, but one possibility is 
that it can be maintained in wildlife, such as deer. SBV has been detected at high 
seroprevalence in deer in a number of European countries, but only once in the UK in a 
single region.   
Methods: The purpose of this study was to survey wild deer across Great Britain for recent 
evidence of SBV. Deer hunters were recruited for the purpose of providing post-mortem 
blood samples to be tested for SBV antibodies. 
Results: The seroprevalence of SBV in the British wild deer population was 13.8%; found in 
red, roe, muntjac and fallow deer species, with more in deer further south. 
Conclusion: These results support the growing concern that SBV is now endemic in Great 
Britain and highlight the need to know the role of wildlife in SBV transmission. 
 
INTRODUCTION 
Schmallenberg virus (SBV) is an orthobunyavirus discovered in Germany in 2011 and carried 
by Culicoides biting midges; these insects are also vectors of bluetongue viruses (BTV) (1). 
From its initial discovery, SBV took just 2 years to reach 27 European countries (2). The 
outbreak resulted in financial losses to farmers as SBV affects domestic ruminants, namely 
sheep and cattle (3). In adult animals, infection causes subclinical or mild disease but 
exposure of pregnant females during key periods of gestation can cause abortion, stillbirth 
and congenital malformations in offspring (4). Treatment is symptomatic only and so 
recommended options for prevention include import bans, the use of insecticides, mating 
livestock to ensure the critical gestation period occurs outside of peak vector season and 
minimizing exposure to the vector in endemic areas (4).  
 
The south and south-east of England were the most affected parts of the UK in the 2011 
outbreak (5). Following what was reported to be a period of absence in 2015 (6), September 
2016 saw the return of SBV to England (7). In contrast to the first UK outbreak, SBV reached 
further north in this second outbreak, with 95 premises in England, 42 in Wales and 2 in 
Scotland affected before April 2017 (7).  
 
SBV has also been detected in deer and has shown high seroprevalence in a number of 
European countries (8). The first evidence of SBV in UK deer during the first outbreak was 
reported in 2012 (9) but only 66 samples from a single region of England were tested. The 
manifestation of this disease in deer is unknown, as is the possibility of transfer between 
species. The nature of rearing wild ruminant offspring and the lack of close monitoring 
mean that disease surveillance in wild deer is generally poor.  
 
Deer may be important reservoirs of SBV between and during outbreaks, contributing to the 
threat that SBV poses to Great Britain and its large farming industry. The purpose of this 
study was to investigate evidence of SBV in British wild deer, determining its 
seroprevalence, geographical distribution and risk factors. 
 
MATERIALS AND METHODS  
Study design 
Ethical approval was granted by the University of Liverpool Veterinary Ethics Board prior to 
commencement of the study (VREC707). Sample size was determined by initially estimating 
the seroprevalence of SBV in wild deer in Europe from published data. Studies on deer SBV 
seroprevalence in European countries, including Belgium, Netherlands, France, Poland, Italy 
and Spain, revealed seroprevalences as high as 40—50% in certain species. Many of these 
estimates were obtained during active outbreaks and may be higher than would be 
expected during inter-epidemic periods. Geographical similarity meant that the 21% 
seroprevalence recorded in Great Britain (9) and 9.9% in Ireland (10) were considered to be 
the most relevant. As the more recent and widespread investigation; the seroprevalence 
recorded in Ireland was deemed the most reliable basis for this study Therefore, to estimate 
sample size, we assumed an initial seroprevalence of 10%. Given diagnostic test sensitivity 
of 97.7% and specificity of 99.7%, we determined that 157 samples were required to 
estimate seroprevalence with 5% precision and 95% confidence. 
 
Participant recruitment 
Deer hunters were recruited to provide post-mortem blood samples to be tested for SBV 
antibodies. The British Deer Society, Deer Initiative and British Association for Shooting and 
Conservation advertised to hunters by email, telephone or visit. All licensed deer hunters 
were considered eligible to participate. Interest was confirmed by email detailing the 
latitude and number of samples they aimed to supply. Following a high level of recruitment, 
deer hunters were selected based on their latitude to give wide coverage of Great Britain. 
 
Materials 
Sample packs were distributed to participants for return to Leahurst Campus, University of 
Liverpool. A sample pack comprised a padded envelope containing a participant information 
sheet, study protocol, participant consent form, record sheet, pair of disposable nitrile 
gloves, disposable pipettes, a blood tube (Sarstedt Ltd, [Leicester, England]), labelled with a 
unique deer ID number and a disposal bag for used materials. The record sheet was used to 
obtain additional information for risk factor analysis including the latitude, habitat, age, sex, 
species and approximate weight of the deer sampled.  
 
Sampling 
Blood samples were collected between February 1, 2019, and March 31, 2019. Samples 
were taken post-mortem from deer shot for routine reasons, ensuring that no deer were 
killed for the purpose of this study. Each sample received was recorded and checked for a 
signed consent form before testing. Once the deer ID number was matched to a participant, 
personal information regarding the deer hunter was kept anonymous and only the deer ID 
number was used thereafter. Blood samples were refrigerated until they could be 
centrifuged and the serum frozen. The maximum period for which a sample was left in the 
fridge before centrifugation was over the weekend when the sample was received late 
Friday afternoon. Most samples were frozen within 2 hours of receipt at Leahurst. 
 
Testing 
Screening for SBV antibodies was done after all the samples were received. In order to avoid 
poor quality samples yielding false ELISA results, 59 samples estimated to have >50 and 
<250 mg/dL haemoglobin concentration, according to their colour, were selected for 
treatment with HemogloBind (Biotech Support Group, New Jersey, USA). Samples with a 
higher concentration than this, totalling 78 samples, were discarded immediately, on the 
assumption that that they were too degraded to be worth treating. Samples with <50mg/dL 
(28 samples) haemoglobin concentration qualified for use in the ELISA without any further 
treatment. Eighty-seven samples were therefore tested by ELISA, including 28 that did not 
require treatment with HemogloBind, were therefore tested by ELISA (ID Screen 
Schmallenberg virus Indirect Multi-species screening test; IDvet [Grabels, France]) according 
to the manufacturer’s instructions.  
 
Risk factor analysis 
The outcome variable, SBV test result, was set as a binary response variable (0= negative; 1 
= positive) 
 
Explanatory variables were species, habitat, age, sex, weight, and latitude, defined as 
follows: species (categorical), red, roe or ‘other’; habitat (categorical), deciduous forest, 
coniferous forest or ‘other’; age (categorical), adult (>2 years), yearling (1—2 years) or 
young (0—1 years); sex (categorical), male or female; weight (continuous, in Kg); latitude 
(continuous - the latitude of the county town from the county where the sample was 
obtained - or categorical, divided according to north/south distribution), Northumberland 
and Cumbria; Yorkshire and Lancashire; or Suffolk, Bedfordshire and Norfolk. 
 
First, univariable analysis of each categorical explanatory variable and the outcome variable 
was carried out using ‘Fisher’s Exact test’ SISA online tool 
(https://www.quantitativeskills.com/sisa/statistics/fiveby2.htm). This was chosen instead of 
chi-squared as there were often expected values of <5. Possible confounding was addressed 
by stratification. 
 
Second, multivariable logistic regression models were developed using R version 3.5.1 
programme. All explanatory variables were included, apart from sex because this variable 
was unbalanced, with only one positive sample obtained from a male. Weight was log-
transformed to reduce right skew. Latitude was continuous. Reference categories of the 
included categorical variables were ‘other’ for species, coniferous forest for habitat, and 
adult for age. There were insufficient sample sizes for us to robustly test for statistical 
interactions between the different explanatory variables. 
 
RESULTS 
A total of 330 sample packs were sent out and 165 (50%) were returned. Due to 
degradation, only 87 of these samples could be tested, which meant that the desired 
confidence and precision set out prior to sampling was not achieved.  
 
In the ELISA, the ratio of the optical density for positive controls to negative controls was 
4.9. For the ELISA to be valid, it must be greater than 3. 
 
The ELISA resulted in 17 positive and 2 doubtful results. An estimate of 22.1% (confidence 
interval, 14.5%—32.1%) seroprevalence of SBV in British wild deer was determined if the 2 
doubtful results are regarded as positive; and 19.7% (CI 12.6%-29.5%) if the 2 doubtful 
results are counted as negative. 
 
Virus neutralisation testing (VNT) by the Animal and Plant Health Agency confirmed twelve 
of these samples as positive for antibodies to SBV, and 7 as negative. Assuming that the VNT 
is the more accurate test these new results estimate a 13.8% (8.1—22.6% confidence 
interval) seroprevalence of SBV in British wild deer.  
 
Positive (by VNT and ELISA) and negative results, by risk factor, are summarised in Table 1. 
 
In univariable analysis, two significant associations were found: the probability of being 
seropositive for SBV was increased if samples were from females or further south (Table 2 
and Figure 1). We attempted to address possible confounding between sex and latitude by 
stratification, testing for an effect of latitude in males and females separately. The effect of 
latitude was significant in females only (females, P < 0.02; males, P > 0.5), consistent with 
confounding, although the sample sizes for males were small, with only a single positive. 
 
Multivariable analysis by logistic regression of all 19 positive and doubtful samples found 
latitude to be a significant variable: seropositivity was associated with samples from deer at 
more southern sites. Analysis of the 12 VNT-positive samples also found only a significant 
association with latitude (see Table 3); as before, samples collected from further south were 
more likely to be SBV positive. 
 
DISCUSSION 
This study provides evidence of continued SBV circulation in deer in Great Britain since 2012 
(9), with a number of positive samples from young deer that were likely born in 2018. SBV 
may be endemic in Great Britain, as it appears to be elsewhere in Europe (11). 
 
A total of 14 ELISA-positive samples out of 66 collected were reported in early Spring 2012 
(9); resulting in an estimated 21.2% seroprevalence. Similarly, our ELISA results yielded an 
estimated 21.8% seroprevalence (19 positive samples out of 87 tested) but confirmatory 
testing by VNT confirmed only 12 of these to be positive (13.8% seroprevalence). With 
approximately 2 million UK wild deer a 14—22% seroprevalence suggests that there may be 
as many as 440,000 deer that have been exposed to SBV. This crude estimate, however, 
does not take account of different seropositivity rates by latitude; for instance, more deer 
are present in Scotland, where we expect SBV rates to be lower.  
 
We found that deer in the south are more likely to be SBV positive; this agrees with previous 
studies reporting a mostly southern distribution of the virus during the 2011 outbreak 
(12;13). Measures to prevent and control the spread of SBV in Great Britain should 
therefore focus mostly on ruminants in southern England; although it is important to note 
that seropositive results were obtained from samples collected as far north as Cumbria and 
cases have occurred in Scotland. 
 
Sampling from hunted animals is often a poor means of estimating disease prevalence, as 
there may be a difference between infected and uninfected animals in their availability to 
hunters. However, we believe this potential source of bias to be minimal for our study of 
SBV. First, we were detecting antibody responses, which, in most cases, will be from historic 
infections. Second, in livestock with active SBV infections the clinical signs are very mild or 
undetectable, and so unlikely to significantly affect behaviour. 
 
Due to fewer samples being received than expected, and the poor quality of some of the 
samples, we were unable to adhere to all details of our study protocol. While we had 
intended that no more than 5 samples should be tested from any single hunter, we tested 
all samples of sufficient quality.  
 
Antibodies to SBV were detected in both yearling (1-2 years) and young (<1 year) deer, 
confirming that SBV has been circulating recently in Great Britain. However, persistent 
maternal antibodies could have given rise to these results in the youngest deer; in Texas, 
maternal antibodies to bluetongue virus were not shown to disappear until the deer were 
23 weeks of age (14). Similarly to the study in Ireland (10), we found higher seroprevalences 
among older deer (20.5% in adults, 7% in yearlings/young combined), although we did not 
find a statistically significant effect of deer age on the probability of a sample being 
seropositive. In an endemic setting, seropositivity rates to a pathogen tend to increase with 
age, as older individuals have had more opportunity to be exposed to an infection and, 
therefore, the pattern we have observed is further evidence for endemic transmission. A 
more highly powered study is recommended to explore in more detail the effect of age on 
deer seropositivity rates. 
 
Six species of deer live freely in Great Britain; of these, muntjac and Chinese water deer are 
not found elsewhere in Europe. We received and tested samples from all six; and four were 
seropositive by VNT. Two of these species (muntjac and fallow) are new reports for SBV in 
GB. In contrast to all other deer species, muntjac breed all year round. This could help SBV 
to persist, with susceptible animals entering the population in all seasons; consequently, the 
presence of muntjac may present an additional disease challenge to Great Britain. In 
Ireland, positive results were recorded in fallow, sika and red deer (3 of the 4 of the species 
tested) and in deer of both sexes (10). Neither the Irish nor the present study found 
evidence that species or sex influence the risk of a deer being SBV seropositive. 
 
Although we received fewer samples than anticipated, advertising for and utilising public 
participants, specifically those involved in deer management, is an effective way of 
improving disease awareness, and achieving cost effective surveillance. Additionally, it can 
ignite interest for involvement in further studies. The fifty percent return rate of samples 
indicates the need to recruit a substantially larger number of participants than is estimated 
to power a study. 
 
This study significantly extends the area over which SBV has been reported in British deer. 
The high seroprevalence of SBV in a large and widespread deer population raises concerns 
around the welfare of wild deer, has implications for the deer farming industry, and 
indicates that deer could act as a source of virus for livestock. The apparent endemicity of 
this Culicoides-borne disease in the UK indicates that we should expect continued challenge 
from this virus, but also heightens concerns about our vulnerability to other viruses spread 
by the same vectors, including BTV and African horse sickness virus (15). Climate change is 
likely to further increase the threat posed by these viruses (16). 
 
The re-emergence of SBV in 2016 and its spread to previously untouched areas alert us to 
the continued threat posed by SBV. Should this pattern of re-emergence continue, then the 
detrimental impacts caused by the disease will continue (1). The results from this study 
should motivate further study and surveillance of SBV in deer. 
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TABLES 
 
Table 1: Detection of antibody to Schmallenberg virus in deer blood samples by enzyme-
linked Immunosorbent assay (ELISA) and virus neutralisation test (VNT). NA – not 
available. 
 
Risk factor Not 
tested 
VNT  
+ve, -ve  
ELISA 
+ve, -ve 
VNT % 
positive 
ELISA % 
positive  
County Cumbria 47 3, 39 8, 34 7.1 19.0 
 Yorkshire 37 2, 15 3, 14 11.8 17.6 
 Suffolk 4 2, 2 2, 2 50 50 
 Northumberland 10 0, 6 0, 6 0 0 
 Bedfordshire 12 1, 6 1, 6 14.3 14.3 
 Lancashire 5 1, 1 1, 1 50 50 
 Norfolk 15 3, 4 4, 3 42.3 57.1 
 East Sussex 1 0, 0 0, 0 0 0 
 Dumfries & Galloway 2 0, 0 0, 0 0 0 
 Wiltshire 1 0, 0 0, 0 0 0 
 Worcestershire 1 0, 0 0, 0 0 0 
 Dorset 3 0, 0 0, 0 0 0 
 Ayrshire 4 0, 0 0, 0 0 0 
 Herefordshire 2 0, 0 0, 0 0 0 
 NA 2 0, 2 0, 2 0 0 
Species Red 24 1, 13 3, 11 7.1 21.4 
 Roe 85 6, 47 11, 42 11.3 20.8 
 Muntjac 20 1, 7 1, 7 12.5 12.5 
 Fallow 11 2, 3 2, 3 40 40 
 Chinese water deer 2 0, 2 0, 2 0 0 
 Sika 2 0, 1 0, 1 0 0 
 NA 2 2, 2 2, 2 50 50 
Sex Female 110 12, 53 18, 47 18.5 27.7 
 Male 34 0, 20 1, 19 0 5 
 NA 2 0, 2 0, 2 0 0 
Habitat  Coniferous Forest 95 8, 48 13, 43 14.3 23.2 
 Deciduous Forest 29 3, 21 5, 19 12.5 20.8 
 Grassland 10 1, 3 1, 3 25 25 
 Other 10 0, 1 0, 1 0  0 
 NA 2 0, 2 0, 2 0 0 
Age Adult 82 8, 31 12, 27 20.5 30.8 
 Yearling 31 2, 21 3, 20 8.7 13.0 
 Young 30 1, 21 3, 19 4.5 13.6 
 NA 3 1, 2 1, 2 33.3 33.3 
Total  142 12, 75 19, 68 13.8 21.8 
 
 
 
Table 2: Univariate analysis using the Fisher Exact test. For latitude, counties were divided 
according to north/south distribution; Northumberland and Cumbria; Yorkshire and 
Lancashire; or Suffolk, Bedfordshire and Norfolk. Significant mid-p values (<0.05) are in bold.  
 
 
 
 
Table 3: Multivariable analysis by logistic regression. Significant P values (<0.05) are in 
bold. The final model was obtained by removing explanatory variables in order of least 
significance and resulted in only latitude as a significant predictor; estimates for the other 
variables were obtained by adding them separately to the final model. 
  
Risk factor Mid-p value 
Latitude 0.012 
Sex 0.045 
Habitat 0.714 
Species 0.580 
Age 0.158 
Risk factor Coefficient S.E. P 
Latitude -0.871 0.360 0.016 
Age(Yearling) -0.432 0.932 0.643 
Age(Young) -1.338 1.124 0.234 
Species(Red Deer) 1.823 1.786 0.307 
Species(Roe Deer) 1.404 1.087 0.197 
Log(Weight) 0.266 0.388 0.494 
Habitat(Deciduous Forest) 0.010 0.760 0.980 
Habitat(Other) 0.225 1.252 0.857 
Figure 1: Map of counties in England showing the number of deer blood samples positive 
and negative for SBV by virus neutralisation test (VNT); only counties from which samples 
were tested are shown. Contains National Statistics data © Crown copyright and database 
right [2011]. Contains OS data © Crown copyright [and database right] (2011 
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